SRRK
Common StockScholar Rock Holding Corp
Reported Shares
9.4M
Position Mix
No options reported
Reported Value
$453.0M
Portfolio Weight
10.71%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$4.2B
Data Refreshed
Nov 16, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
SRRK
Common StockScholar Rock Holding Corp
Reported Shares
9.4M
Position Mix
No options reported
Reported Value
$453.0M
Portfolio Weight
10.71%
KYMR
Common StockKymera Therapeutics, Inc.
Reported Shares
2.8M
Position Mix
No options reported
Reported Value
$311.3M
Portfolio Weight
7.36%
ERAS
Common StockErasca, Inc.
Reported Shares
13.2M
Position Mix
No options reported
Reported Value
$193.5M
Portfolio Weight
4.57%
RVMD
Common StockRevolution Medicines, Inc.
Reported Shares
850K
Position Mix
No options reported
Reported Value
$174.5M
Portfolio Weight
4.12%
ONC
Depositary ReceiptBeOne Medicines Ltd.
Reported Shares
465K
Position Mix
No options reported
Reported Value
$170.2M
Portfolio Weight
4.02%
TNGX
Common StockTango Therapeutics, Inc.
Reported Shares
6.8M
Position Mix
No options reported
Reported Value
$169.3M
Portfolio Weight
4.00%
MANE
Common StockVeradermics, Inc
Reported Shares
1.3M
Position Mix
No options reported
Reported Value
$160.5M
Portfolio Weight
3.79%
ARWR
Common StockARROWHEAD PHARMACEUTICALS, INC.
Reported Shares
2.3M
Position Mix
No options reported
Reported Value
$149.9M
Portfolio Weight
3.54%
EWTX
Common StockEdgewise Therapeutics, Inc.
Reported Shares
2.8M
Position Mix
No options reported
Reported Value
$113.8M
Portfolio Weight
2.69%
RYTM
Common StockRHYTHM PHARMACEUTICALS, INC.
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$103.4M
Portfolio Weight
2.44%
BCAX
Common StockBicara Therapeutics Inc.
Reported Shares
5.5M
Position Mix
No options reported
Reported Value
$102.4M
Portfolio Weight
2.42%
PBLS
Common StockParabilis Medicines, Inc.
Reported Shares
3M
Position Mix
No options reported
Reported Value
$96.6M
Portfolio Weight
2.28%
LXRX
Common StockLEXICON PHARMACEUTICALS, INC.
Reported Shares
44.3M
Position Mix
No options reported
Reported Value
$83.3M
Portfolio Weight
1.97%
SYRE
Common StockSpyre Therapeutics, Inc.
Reported Shares
868.6K
Position Mix
No options reported
Reported Value
$77.3M
Portfolio Weight
1.83%
TYRA
Common StockTyra Biosciences, Inc.
Reported Shares
3.4M
Position Mix
No options reported
Reported Value
$74.3M
Portfolio Weight
1.76%
COAG
Common StockHemab Therapeutics Holdings, Inc.
Reported Shares
2.4M
Position Mix
No options reported
Reported Value
$73.0M
Portfolio Weight
1.72%
AMLX
Common StockAmylyx Pharmaceuticals, Inc.
Reported Shares
2.5M
Position Mix
No options reported
Reported Value
$72.2M
Portfolio Weight
1.71%
ELVN
Common StockEnliven Therapeutics, Inc.
Reported Shares
1.5M
Position Mix
No options reported
Reported Value
$67.6M
Portfolio Weight
1.60%
SEPN
Common StockSepterna, Inc.
Reported Shares
1.7M
Position Mix
No options reported
Reported Value
$66.5M
Portfolio Weight
1.57%
RCUS
Common StockArcus Biosciences, Inc.
Reported Shares
2.4M
Position Mix
No options reported
Reported Value
$62.5M
Portfolio Weight
1.48%